XBiotech XBIT Stock
$2.31
0.873362%
Add to favorites
SECTOR
INDUSTRY
COUNTRY
Exchange
Market Cap
$70.43M
LOW - HIGH [24H]
$2.28
-
$2.31
VOLUME [24H]
$16.45K
P/E Ratio
0
Earnings per share
-$1.31
ISIN
CA98400H1029
XBiotech Price Chart
XBiotech XBIT Financial and Trading Overview
| XBiotech stock price | 2.31 USD |
| Previous Close | 2.33 USD |
| Open | 2.32 USD |
| Bid | 1.65 USD x 200 |
| Ask | 2.99 USD x 200 |
| Day's Range | 2.29 - 2.33 USD |
| 52 Week Range | 2.09 - 3.61 USD |
| Volume | 15.5K USD |
| Avg. Volume | 30.12K USD |
| Market Cap | 70.27M USD |
| Beta (5Y Monthly) | 0.844 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.31 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | July 15, 2021 |
| 1y Target Est | N/A |
XBIT Valuation Measures
| Enterprise Value | -44422588 USD |
| Trailing P/E | N/A |
| Forward P/E | 17.73077 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.52043355 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.949 |
Trading Information
XBiotech Stock Price History
| Beta (5Y Monthly) | 0.844 |
| 52-Week Change | -15.27% |
| S&P500 52-Week Change | 20.36% |
| 52 Week High | 3.61 USD |
| 52 Week Low | 2.09 USD |
| 50-Day Moving Average | 2.4 USD |
| 200-Day Moving Average | 2.44 USD |
XBIT Share Statistics
| Avg. Volume (3 month) | 30.12K USD |
| Avg. Daily Volume (10-Days) | 39.12K USD |
| Shares Outstanding | 30.49M |
| Float | 22.84M |
| Short Ratio | 8.41 |
| % Held by Insiders | 24.32% |
| % Held by Institutions | 6.81% |
| Shares Short | 275.57K |
| Short % of Float | 1.06% |
| Short % of Shares Outstanding | 0.89% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -18.80% |
| Return on Equity (ttm) | -25.93% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -46833000 USD |
| Net Income Avi to Common (ttm) | -40161000 USD |
| Diluted EPS (ttm) | -1.31 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 115.46M USD |
| Total Cash Per Share (mrq) | 3.79 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 39.029 |
| Book Value Per Share (mrq) | 4.429 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -42169000 USD |
| Levered Free Cash Flow (ttm) | -30622624 USD |
Profile of XBiotech
| Country | United States |
| State | TX |
| City | Austin |
| Address | 5217 Winnebago Lane |
| ZIP | 78744 |
| Phone | 512 386 2900 |
| Website | https://www.xbiotech.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 87 |
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Q&A For XBiotech Stock
What is a current XBIT stock price?
XBiotech XBIT stock price today per share is 2.31 USD.
How to purchase XBiotech stock?
You can buy XBIT shares on the Tech Market Large exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for XBiotech?
The stock symbol or ticker of XBiotech is XBIT.
Which industry does the XBiotech company belong to?
The XBiotech industry is Biotechnology.
How many shares does XBiotech have in circulation?
The max supply of XBiotech shares is 30.49M.
What is XBiotech Price to Earnings Ratio (PE Ratio)?
XBiotech PE Ratio is now.
What was XBiotech earnings per share over the trailing 12 months (TTM)?
XBiotech EPS is -1.31 USD over the trailing 12 months.
Which sector does the XBiotech company belong to?
The XBiotech sector is Healthcare.
XBiotech XBIT included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26192.48 USD — |
+0.33
|
3.76B USD — | 26041.13 USD — | 26316.81 USD — | — - | 3.76B USD — |
|
US Tech Biotechnology Total Retu
XNBI
US
|
7142.32 USD — |
+0.43
|
— — | 7044.78 USD — | 7147.73 USD — | — - | — — |
|
US Tech Global Select Market Com
NQGS
US
|
12856.41 USD — |
+0.32
|
— — | 12785.35 USD — | 12920.04 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1250.52 USD — |
+0.75
|
— — | 1233.72 USD — | 1252.43 USD — | — - | — — |
|
US Tech Composite Total Return
XCMP
US
|
32305.8 USD — |
+0.31
|
— — | 32125.24 USD — | 32465.34 USD — | — - | — — |
- {{ link.label }} {{link}}